The funding will scale the brand’s UK presence, accelerate international growth and expand its fast-growing product portfolio of digestive supplements.

Founded by Scottish health-supplements entrepreneur Gemma Stuart, Gutsy Health was born from her own 15-year battle with IBS, a condition affecting one in 20 people in the UK and linked to an estimated £3 billion in annual lost sick days.

After years of bloating, cramping and finding nothing in the UK market that consistently helped, Ms Stuart set out to create simple, science-led products using clinically studied postbiotics and targeted nutrients to support bowel regularity and calmer digestion. 

Gut Wealth products use a clinically studied postbiotic that’s safe, stable and doesn’t require refrigeration, plus targeted vitamins and minerals for overall digestive support. Working with specialists and drawing on her study of IBS management, Ms Stuart developed a trusted formula designed to calm uncomfortable gut symptoms.

The Gut Wealth range has already earned industry recognition, including a Scottish EDGE Award and the UK StartUp Award for MedTech & HealthTech of the Year.

The new investment will support the growth of Gutsy Health’s flagship liquid supplement and drive wider retail distribution across pharmacies, health stores and national retailers. It will also accelerate ecommerce expansion, including Amazon, and fuel new product development following the launch of its lighter, easier-to-store capsule formulation designed to widen accessibility across the UK and Ireland.

Ms Stuart, founder of Gutsy Health, said: “We’re helping thousands of people live freely from the pain and shame of gut ill-health so they aren’t held back from work, social plans or worrying what their gut is going to do next.

“I created Gut Wealth from my own experience of irritable bowels, and in 2026 I’ll be growing our team as we scale from our core direct-to-consumer sales into national retailers and international markets.

“This investment from Equity Gap, Apollo and Scottish Enterprise means we can reach more people with our science-led digestive supplements that are simple to use and genuinely life-improving. People shouldn’t have to suffer in silence with bloating, cramping or those dreaded toilet dashes. Gut Wealth liquids and capsules make it easy to make a daily good-gut choice.”

Fraser Lusty, managing director of Equity Gap, said: “We’re seeing digestive health become one of the most urgent and underserved wellbeing challenges in the UK, and consumers are increasingly demanding solutions that are science-led, not trend-led.

“Gutsy Health is tapping directly into that shift. Gemma’s understanding of the market, her personal insight into the consumer struggle, and the quality of the science behind her products made this a compelling investment case for us. With new product development underway, Gut Wealth is well placed to become a leading UK player in digestive wellness.”

Michiel Smith, director of Apollo Informal Investments, added: “The gut health supplement industry is expanding, with increasing consumer interest in the link between gut health, immunity, and overall well-being.

“Gut Wealth’s unique, science-led formula has received high praise from its customers online. We strongly believe in the company’s growth potential and are very excited to become a part of its journey.”